GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
Synonyms: N-docosahexaenoylethanolamine
Compound class:
Synthetic organic
Comment: Synaptamide is an endocannabinoid-like derivative of docosahexaenoic acid (DHA) that is biosynthesised in the brain. It has cannabinoid-independent activities.
|
|
References |
1. Abdulkareem NM, Bhat R, Castillo M, Jung SY, Vasaikar S, Nanda S, Ruiz A, Shea M, Cao W, Veeraraghavan J et al.. (2025)
Interactions between ADGRF1 (GPR110) and extracellular matrix proteins govern its effects on tumorigenesis in HER2-positive breast cancer. Br J Pharmacol, 182 (11): 2524-2541. [PMID:39965212] |
2. Abdulkareem NM, Bhat R, Qin L, Vasaikar S, Gopinathan A, Mitchell T, Shea MJ, Nanda S, Thangavel H, Zhang B et al.. (2021)
A novel role of ADGRF1 (GPR110) in promoting cellular quiescence and chemoresistance in human epidermal growth factor receptor 2-positive breast cancer. FASEB J, 35 (7): e21719. [PMID:34110646] |
3. Demberg LM, Winkler J, Wilde C, Simon KU, Schön J, Rothemund S, Schöneberg T, Prömel S, Liebscher I. (2017)
Activation of Adhesion G Protein-coupled Receptors: AGONIST SPECIFICITY OF STACHEL SEQUENCE-DERIVED PEPTIDES. J Biol Chem, 292 (11): 4383-4394. [PMID:28154189] |
4. Jones DTD, Dates AN, Rawson SD, Burruss MM, Lipper CH, Blacklow SC. (2023)
Tethered agonist activated ADGRF1 structure and signalling analysis reveal basis for G protein coupling. Nat Commun, 14 (1): 2490. [PMID:37120430] |
5. Kwon HS, Kevala K, Qian H, Abu-Asab M, Patnaik S, Marugan J, Kim HY. (2023)
Ligand-Induced Activation of GPR110 (ADGRF1) to Improve Visual Function Impaired by Optic Nerve Injury. Int J Mol Sci, 24 (6). [PMID:36982411] |
6. Lee JW, Huang BX, Kwon H, Rashid MA, Kharebava G, Desai A, Patnaik S, Marugan J, Kim HY. (2016)
Orphan GPR110 (ADGRF1) targeted by N-docosahexaenoylethanolamine in development of neurons and cognitive function. Nat Commun, 7: 13123. [PMID:27759003] |
7. Lei P, Wang H, Yu L, Xu C, Sun H, Lyu Y, Li L, Zhang DL. (2022)
A correlation study of adhesion G protein-coupled receptors as potential therapeutic targets in Uterine Corpus Endometrial cancer. Int Immunopharmacol, 108: 108743. [PMID:35413679] |
8. Lum AM, Wang BB, Beck-Engeser GB, Li L, Channa N, Wabl M. (2010)
Orphan receptor GPR110, an oncogene overexpressed in lung and prostate cancer. BMC Cancer, 10: 40. [PMID:20149256] |
9. Prömel S, Waller-Evans H, Dixon J, Zahn D, Colledge WH, Doran J, Carlton MB, Grosse J, Schöneberg T, Russ AP et al.. (2012)
Characterization and functional study of a cluster of four highly conserved orphan adhesion-GPCR in mouse. Dev Dyn, 241 (10): 1591-602. [PMID:22837050] |
10. Qu X, Qiu N, Wang M, Zhang B, Du J, Zhong Z, Xu W, Chu X, Ma L, Yi C et al.. (2022)
Structural basis of tethered agonism of the adhesion GPCRs ADGRD1 and ADGRF1. Nature, 604 (7907): 779-785. [PMID:35418679] |
11. Steichen H, Xue J, Zaidman NA. (2025)
Identification and localization of adhesion G protein-coupled receptor expression in the murine kidney. Am J Physiol Renal Physiol, 329 (1): F11-F19. [PMID:40372763] |
12. Stoveken HM, Hajduczok AG, Xu L, Tall GG. (2015)
Adhesion G protein-coupled receptors are activated by exposure of a cryptic tethered agonist. Proc Natl Acad Sci USA, 112 (19): 6194-9. [PMID:25918380] |
13. Wang F, Wang Y, Qiu W, Zhang Q, Yang H, Song G. (2023)
Crystal Structure of the Extracellular Domains of GPR110. J Mol Biol, 435 (6): 167979. [PMID:36716818] |
14. Wu M, Lo TH, Li L, Sun J, Deng C, Chan KY, Li X, Yeh ST, Lee JTH, Lui PPY et al.. (2023)
Amelioration of non-alcoholic fatty liver disease by targeting adhesion G protein-coupled receptor F1 (Adgrf1). Elife, 12. [PMID:37580962] |
15. Zhu X, Qian Y, Li X, Xu Z, Xia R, Wang N, Liang J, Yin H, Zhang A, Guo C et al.. (2022)
Structural basis of adhesion GPCR GPR110 activation by stalk peptide and G-proteins coupling. Nat Commun, 13 (1): 5513. [PMID:36127364] |